Catina Allen, N.P.; Decision and Order
The DEA issued a Decision and Order regarding Catina Allen, N.P., likely involving a controlled substance registration action. Specific details are not provided in the excerpt.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 25, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Catina Allen, N.P., and potentially other nurse practitioners or healthcare providers with DEA registrations. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the provided text.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
A DEA Decision and Order has been issued; the specific changes or actions are not detailed in the provided text.
Who it affects
Catina Allen, N.P., and potentially other nurse practitioners or healthcare providers with DEA registrations.
What you must do
Review the full Decision and Order to understand any specific requirements or restrictions.
Deadline
Not specified in the provided text.
Source: https://www.federalregister.gov/documents/2026/08/25/2026-17275/catina-allen-np-decision-and-order
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments
- PA HB 2749: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.
- Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
- US-CONGRESS BILLS-119hr10133ih: Fair Prescription Pricing Act of 2026